Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000935836-24-000317
Filing Date
2024-03-26
Accepted
2024-03-26 12:00:09
Documents
1
Period of Report
2024-03-08

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3756
  Complete submission text file 0000935836-24-000317.txt   5514
Mailing Address 357 TEHAMA STREET #3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET #3 SAN FRANCISCO CA 94103 415-448-6534
EcoR1 Capital, LLC (Reporting) CIK: 0001587114 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37368 | Film No.: 24782137

Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)